Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age (original) (raw)
Prediction of chemotherapy adverse reactions and mortality in older patients with primary lung cancer through frailty index based on routine laboratory data
Qiukui Hao
Clinical Interventions in Aging, 2019
View PDFchevron_right
Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy
Vani Katheria
Cancer, 2016
View PDFchevron_right
Frailty and Vulnerability as Predictors of Chemotherapy Toxicity in Older Adults: A Longitudinal Study in Peru
Jose F. Parodi
The journal of nutrition, health & aging, 2020
View PDFchevron_right
Frailty status but not age predicts complications in elderly cancer patients: a follow-up study
Peter Meldgaard
Acta Oncologica
View PDFchevron_right
Validation of a frailty index in older cancer patients with solid tumours
Ruth Hubbard
BMC Cancer, 2018
View PDFchevron_right
Usefulness of Frailty Markers in the Assessment of the Health and Functional Status of Older Cancer Patients Referred for Chemotherapy: A Pilot Study
Doreen Wan-chow-wah
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2008
View PDFchevron_right
Chemotherapy Toxicity in Older Adults Optimized by Geriatric Assessment and Intervention: A Non-Comparative Analysis
Munzir Hamid
Current Oncology
View PDFchevron_right
The impact of low-grade toxicity in older people with cancer undergoing chemotherapy
Tania Kalsi
British Journal of Cancer
View PDFchevron_right
Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy
Luis Aguirre Tipismana
View PDFchevron_right
Use of a Chemotherapy Toxicity Prediction Tool to Decrease Risks for Hospitalization in Older Patients
Wilfred dela Cruz
Cureus, 2022
View PDFchevron_right
Frailty screening for predicting rapid functional decline, rapid progressive disease, and shorter overall survival in older patients with gastrointestinal cancer receiving palliative chemotherapy - a prospective, clinical study
Lisbeth Kirstine Rosenbek Minet
Journal of Geriatric Oncology, 2020
View PDFchevron_right
Frail old patients as a target population for cancer trials
Jean-Pierre MICHEL
The Journal of Nutrition, Health and Aging, 2009
View PDFchevron_right
The frailty syndrome: a critical issue in geriatric oncology
Dan Longo
Critical Reviews in Oncology/Hematology, 2003
View PDFchevron_right
Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer
Vani Katheria
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016
View PDFchevron_right
Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer
Nadine Houédé
Journal of Clinical Oncology, 2012
View PDFchevron_right
Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy
James F Cleary
Cancer Chemotherapy and Pharmacology, 2010
View PDFchevron_right
Toxicity of Cancer Therapies in Older Patients
Claire FALANDRY
Current Oncology Reports, 2018
View PDFchevron_right
Predictors of treatment failures during chemotherapy: A prospective study on 110 older cancer patients
Maria Stasi
Archives of Gerontology and Geriatrics, 2009
View PDFchevron_right
Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy
Dirk Schrijvers
Journal of Geriatric Oncology, 2014
View PDFchevron_right
Clinical factors associated with the therapeutic outcome of chemotherapy in very elderly cancer patients
Takeshi Terui
International Journal of Clinical Oncology, 2019
View PDFchevron_right
Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group
J. Schrama
The Breast, 2014
View PDFchevron_right
Performance of Four Frailty Classifications in Older Patients With Cancer: Prospective Elderly Cancer Patients Cohort Study
Sylvie Bastuji-garin
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017
View PDFchevron_right
Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age
Ulrich Wedding
Haematologica, 2020
View PDFchevron_right
Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study
Tejaswee Hatkhambkar
BMJ Open, 2021
View PDFchevron_right
Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy
Gary Lyman
Cancer, 2007
View PDFchevron_right
An evaluation of cancer aging research group (CARG) score to predict chemotherapy toxicity in older Iranian patients with cancer
ahmad alipour
Oncologie, 2023
View PDFchevron_right
International Survey on Frailty Assessment in Patients with Cancer
Lucia Garetto
The Oncologist
View PDFchevron_right
Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review
Carolien Smorenburg
The Lancet Oncology, 2012
View PDFchevron_right
Tolerance to Chemotherapy in Elderly Patients with Cancer
Ulrich Wedding
Cancer Control, 2007
View PDFchevron_right
Cancer chemotherapy in the elderly: a series of 51 patients aged>70 years
Binh Bui
Cancer Chemotherapy and Pharmacology, 1991
View PDFchevron_right
Estimating the Risk of Chemotherapy Toxicity in Indian Geriatric Patient Population and Utility of Chemotherapy Risk Assessment Scale for High Age Patients (CRASH) Score
aditi mittal
South Asian Journal of Cancer
View PDFchevron_right